RadiotherapyRadiotherapy DosageRadiotherapy, AdjuvantChemotherapy, AdjuvantRadiotherapy, ConformalAdjuvants, ImmunologicCombined Modality TherapyRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyFreund's AdjuvantDose FractionationRadiation InjuriesRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedTreatment OutcomeNeoplasm Recurrence, LocalNeoplasm StagingRadiation OncologyAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalBreast NeoplasmsBrachytherapyAdjuvants, PharmaceuticRadiosurgeryHead and Neck NeoplasmsDose-Response Relationship, RadiationSurvival AnalysisSurvival RatePrognosisRetrospective StudiesChemoradiotherapyFollow-Up StudiesBrain NeoplasmsFluorouracilNasopharyngeal NeoplasmsCarcinoma, Squamous CellRectal NeoplasmsLung NeoplasmsCisplatinRadiation ToleranceOrgans at RiskRadiation-Sensitizing AgentsAntineoplastic AgentsMastectomy, SegmentalParticle AcceleratorsNeoadjuvant TherapyCranial IrradiationTime FactorsProstatic NeoplasmsRadiometryLymphatic MetastasisRadiation DosageCyclophosphamideAdenocarcinomaDacarbazineVincristineRadiation PneumonitisNeoplasms, Second PrimaryPelvic NeoplasmsLaryngeal NeoplasmsAntineoplastic Agents, HormonalRadiodermatitisMastectomyHodgkin DiseaseTomography, X-Ray ComputedNeoplasms, Radiation-InducedNeoplasmsProcarbazineDoxorubicinKaplan-Meier EstimateHeavy Ion RadiotherapyAluminum HydroxideOrgan Sparing TreatmentsTamoxifenCarcinoma, Non-Small-Cell LungXerostomiaCarcinomaDrug Administration ScheduleSpinal NeoplasmsRadioisotope TeletherapyPalliative CareProspective StudiesGlioblastomaAntineoplastic Agents, AlkylatingSarcomaLymphatic IrradiationMethotrexateUterine Cervical NeoplasmsNeoplasm MetastasisMechlorethamineCobalt RadioisotopesSalvage TherapyImmunizationBleomycinVinblastineRadiation-Protective AgentsGliomaClinical Trials as TopicPelvis